Skip to Main Content

Sight Sciences, Inc. Common Stock

SGHT Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
SGHT Income Statement
SGHT Balance Sheet
SGHT Cash Flow

Recent trades of SGHT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
SGHT Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
SGHT Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
SGHT Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by SGHT's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Ocular delivery systems and methods Oct. 29, 2024
  • Patent Title: Ocular delivery systems and methods Oct. 29, 2024
  • Patent Title: Ocular delivery systems and methods Jul. 23, 2024
  • Patent Title: Ocular delivery systems and methods Apr. 09, 2024
  • Patent Title: Formulations and methods for treating conditions of the eye Mar. 12, 2024
  • Patent Title: Devices and methods for intraocular tissue manipulation Jan. 23, 2024
  • Patent Title: Ocular delivery systems and methods Jan. 16, 2024
  • Patent Title: Intraocular implants and methods and kits therefor Jan. 09, 2024
  • Patent Title: Ocular delivery systems and methods Jan. 02, 2024
  • Patent Title: Ocular delivery systems and methods Apr. 04, 2023
  • Patent Title: Formulations and methods for treating conditions of the eye Jan. 17, 2023
  • Patent Title: Ocular delivery systems and methods Nov. 22, 2022
  • Patent Title: Ocular delivery systems and methods Oct. 18, 2022
  • Patent Title: Formulations and methods for treating conditions of the eye Aug. 23, 2022
  • Patent Title: Intraocular implants and methods and kits therefor Jul. 19, 2022
  • Patent Title: Ocular delivery systems and methods Jul. 19, 2022
  • Patent Title: Ocular delivery systems and methods May. 31, 2022
  • Patent Title: Combination treatment systems Mar. 29, 2022
  • Patent Title: Intraocular implants and related kits and methods Nov. 09, 2021
  • Patent Title: Ocular delivery systems and methods Sep. 14, 2021
  • Patent Title: Ocular delivery systems and methods Aug. 17, 2021
  • Patent Title: Controller for dry eye treatment systems Apr. 13, 2021
  • Patent Title: Dry eye treatment systems Feb. 23, 2021
  • Patent Title: Ocular delivery systems and methods Jan. 12, 2021
  • Patent Title: Ocular delivery systems and methods Dec. 08, 2020
  • Patent Title: Dry eye treatment apparatus and methods Sep. 15, 2020
  • Patent Title: Intraocular implants and related kits and methods Sep. 10, 2019
  • Patent Title: Intraocular implants and methods and kits therefor Sep. 03, 2019
  • Patent Title: Intraocular implants and methods and kits therefor Jun. 11, 2019
  • Patent Title: Ocular delivery systems and methods May. 28, 2019
  • Patent Title: Ocular delivery systems and methods Jan. 15, 2019
  • Patent Title: Dry eye treatment systems Aug. 21, 2018
  • Patent Title: Ocular delivery systems and methods Feb. 20, 2018
  • Patent Title: Ocular delivery systems and methods Jan. 02, 2018
  • Patent Title: Dry eye treatment systems Dec. 19, 2017
  • Patent Title: Dry eye treatment apparatus and methods Aug. 08, 2017
  • Patent Title: Methods for improving contact lens comfort May. 09, 2017
  • Patent Title: Dry eye treatment systems Dec. 06, 2016
  • Patent Title: Intraocular implants and methods and kits therefor Nov. 08, 2016
  • Patent Title: Intraocular implants and methods and kits therefor Jun. 21, 2016
  • Patent Title: Ocular delivery systems and methods Dec. 22, 2015
  • Patent Title: Ocular delivery systems and methods Aug. 04, 2015
  • Patent Title: Ocular delivery systems and methods Nov. 25, 2014
  • Patent Title: Intraocular implants and related kits and methods Nov. 04, 2014
  • Patent Title: Intraocular implants and related kits and methods Sep. 10, 2013
  • Patent Title: Intraocular implants and related kits and methods May. 14, 2013
  • Patent Title: Intraocular implants and methods and kits therefor Oct. 16, 2012
  • Patent Title: Intraocular implants and methods and kits therefor Mar. 22, 2011
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of SGHT in WallStreetBets Daily Discussion

SGHT News

Recent insights relating to SGHT

CNBC Recommendations

Recent picks made for SGHT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in SGHT

SGHT Top Shareholders
Shareholder
Shares Held
SGHT Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

SGHT Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view SGHT Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top